File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.ecoenv.2024.116245
- Scopus: eid_2-s2.0-85188615439
- PMID: 38520807
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Chronic exposure to ambient air pollution and the risk of non-alcoholic fatty liver disease: A cross-sectional study in Taiwan and Hong Kong
Title | Chronic exposure to ambient air pollution and the risk of non-alcoholic fatty liver disease: A cross-sectional study in Taiwan and Hong Kong |
---|---|
Authors | |
Keywords | Advanced fibrosis Fine particulate matter Nitrogen dioxide Non-alcoholic fatty liver disease Ozone |
Issue Date | 22-Mar-2024 |
Publisher | Elsevier |
Citation | Ecotoxicology and Environmental Safety, 2024, v. 275 How to Cite? |
Abstract | Background: Information on the relation of air pollution with non-alcoholic fatty liver disease (NAFLD) is scarce. We thus conducted a large cross-sectional study in Asia to investigate the role of air pollution in NAFLD. Methods: We recruited 329,048 adults (mean age: 41.0 years) without other liver disease (hepatitis and cirrhosis) or excessive alcohol consumption in Taiwan and Hong Kong from 2001 to 2018. The concentrations of nitrogen dioxide (NO2) and ozone (O3) were estimated using a space–time regression model, and the concentrations of fine particulate matter (PM2.5) was evaluated using a satellite-based spatio-temporal model. NAFLD was determined using either the fatty liver index (FLI) or the hepatic steatosis index (HSI). The NAFLD-related advanced fibrosis was defined according to BARD score or the fibrosis-4 (FIB-4). A logistic regression model was adopted to explore the relationships of ambient air pollution with the odds of NAFLD and NAFLD-related advanced fibrosis. Results: We found positive relationships between PM2.5 and the odds of NAFLD and advanced fibrosis, with every standard deviation (SD, 7.5 µg/m3) increases in PM2.5 exposure being associated with a 10% (95% confidence interval [CI]: 9%–11%) increment in the prevalence of NAFLD and an 8% (95% CI: 7%–9%) increment in the prevalence of advanced fibrosis. Similarly, the prevalence of NAFLD and advanced fibrosis increased by 8% (95% CI: 7%–9%) and 7% (95% CI: 6%–8%) with per SD (18.9 µg/m3) increasement in NO2 concentration, respectively. Additionally, for every SD (9.9 µg/m3) increasement in O3 concentration, the prevalence of NAFLD and advanced fibrosis decreased by 12% (95% CI: 11%–13%) and 11% (95% CI: 9%–12%), respectively. Conclusion: Higher ambient PM2.5 and NO2 are linked with higher odds of NAFLD and advanced fibrosis. Our findings indicate that reducing PM2.5 and NO2 concentrations may be an effective way for preventing NAFLD. Further studies on O3 are warranted. |
Persistent Identifier | http://hdl.handle.net/10722/347257 |
ISSN | 2023 Impact Factor: 6.2 2023 SCImago Journal Rankings: 1.418 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Bo, Yacong | - |
dc.contributor.author | Lin, Changqing | - |
dc.contributor.author | Guo, Cui | - |
dc.contributor.author | Wong, Martin | - |
dc.contributor.author | Huang, Bo | - |
dc.contributor.author | Lau, Alexis | - |
dc.contributor.author | Huang, Yu | - |
dc.contributor.author | Lao, Xiang Qian | - |
dc.date.accessioned | 2024-09-20T00:31:00Z | - |
dc.date.available | 2024-09-20T00:31:00Z | - |
dc.date.issued | 2024-03-22 | - |
dc.identifier.citation | Ecotoxicology and Environmental Safety, 2024, v. 275 | - |
dc.identifier.issn | 0147-6513 | - |
dc.identifier.uri | http://hdl.handle.net/10722/347257 | - |
dc.description.abstract | Background: Information on the relation of air pollution with non-alcoholic fatty liver disease (NAFLD) is scarce. We thus conducted a large cross-sectional study in Asia to investigate the role of air pollution in NAFLD. Methods: We recruited 329,048 adults (mean age: 41.0 years) without other liver disease (hepatitis and cirrhosis) or excessive alcohol consumption in Taiwan and Hong Kong from 2001 to 2018. The concentrations of nitrogen dioxide (NO2) and ozone (O3) were estimated using a space–time regression model, and the concentrations of fine particulate matter (PM2.5) was evaluated using a satellite-based spatio-temporal model. NAFLD was determined using either the fatty liver index (FLI) or the hepatic steatosis index (HSI). The NAFLD-related advanced fibrosis was defined according to BARD score or the fibrosis-4 (FIB-4). A logistic regression model was adopted to explore the relationships of ambient air pollution with the odds of NAFLD and NAFLD-related advanced fibrosis. Results: We found positive relationships between PM2.5 and the odds of NAFLD and advanced fibrosis, with every standard deviation (SD, 7.5 µg/m3) increases in PM2.5 exposure being associated with a 10% (95% confidence interval [CI]: 9%–11%) increment in the prevalence of NAFLD and an 8% (95% CI: 7%–9%) increment in the prevalence of advanced fibrosis. Similarly, the prevalence of NAFLD and advanced fibrosis increased by 8% (95% CI: 7%–9%) and 7% (95% CI: 6%–8%) with per SD (18.9 µg/m3) increasement in NO2 concentration, respectively. Additionally, for every SD (9.9 µg/m3) increasement in O3 concentration, the prevalence of NAFLD and advanced fibrosis decreased by 12% (95% CI: 11%–13%) and 11% (95% CI: 9%–12%), respectively. Conclusion: Higher ambient PM2.5 and NO2 are linked with higher odds of NAFLD and advanced fibrosis. Our findings indicate that reducing PM2.5 and NO2 concentrations may be an effective way for preventing NAFLD. Further studies on O3 are warranted. | - |
dc.language | eng | - |
dc.publisher | Elsevier | - |
dc.relation.ispartof | Ecotoxicology and Environmental Safety | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.subject | Advanced fibrosis | - |
dc.subject | Fine particulate matter | - |
dc.subject | Nitrogen dioxide | - |
dc.subject | Non-alcoholic fatty liver disease | - |
dc.subject | Ozone | - |
dc.title | Chronic exposure to ambient air pollution and the risk of non-alcoholic fatty liver disease: A cross-sectional study in Taiwan and Hong Kong | - |
dc.type | Article | - |
dc.description.nature | published_or_final_version | - |
dc.identifier.doi | 10.1016/j.ecoenv.2024.116245 | - |
dc.identifier.pmid | 38520807 | - |
dc.identifier.scopus | eid_2-s2.0-85188615439 | - |
dc.identifier.volume | 275 | - |
dc.identifier.issnl | 0147-6513 | - |